Vaccino epatite b dna ricombinante

Fendrix

Sospensione iniettabileItalyAuthorised

Packs

Pack	Code	Status
SOSPENSIONE PER USO INIETTABILE USO INTRAMUSCOLARE SIRINGA PRERIEMPITA VETRO 0,5ML 1 SIRINGA PRERIEMPITA + 1 AGO	036776019	Autorizzata
SOSPENSIONE PER USO INIETTABILE USO INTRAMUSCOLARE SIRINGA PRERIEMPITA VETRO 0,5ML 1 SIRINGA PRERIEMPITA	036776021	Autorizzata
SOSPENSIONE PER USO INIETTABILE USO INTRAMUSCOLARE SIRINGA PRERIEMPITA VETRO 0,5ML 10 SIRINGHE PRERIEMPITE	036776033	Autorizzata

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Vaccino epatite b dna ricombinante

Fendrix

Sospensione iniettabileItalyAuthorised

Product informationAsk Osler about it

Packs

Pack	Code	Status
SOSPENSIONE PER USO INIETTABILE USO INTRAMUSCOLARE SIRINGA PRERIEMPITA VETRO 0,5ML 1 SIRINGA PRERIEMPITA + 1 AGO	036776019	Autorizzata
SOSPENSIONE PER USO INIETTABILE USO INTRAMUSCOLARE SIRINGA PRERIEMPITA VETRO 0,5ML 1 SIRINGA PRERIEMPITA	036776021	Autorizzata
SOSPENSIONE PER USO INIETTABILE USO INTRAMUSCOLARE SIRINGA PRERIEMPITA VETRO 0,5ML 10 SIRINGHE PRERIEMPITE	036776033	Autorizzata

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Vaccino epatite b dna ricombinante
Dosage form: Sospensione iniettabile
Register: Italy (AIFA)
Status: Authorised
Status in the register: Autorizzata
Registration: AIC 036776
Marketing authorisation holder: Glaxosmithkline Biologicals S.A.
ATC code: J07BC01
Group: Anti-infectives for systemic use
Procedure: Procedura Centralizzata
Supply: Medicinali soggetti a prescrizione medica